Based on expression levels, nine genes—NRG3, IL1RAP, PMAIP1, STRADA, SGK3, LAMTOR4, MAPK12, PHB, and GRB2—separated AD patients into low- and high-risk groups with different disease survival (P < 0.05). This evidence concerns the gene IL1RAP and Alzheimer disease.